Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.74 |
| ▸ | TSHR | P16473 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | HTT | P42858 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | CCKBR | P32239 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1934409 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL28642718 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL28662843 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL29379056 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL31310810 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL5680135 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL18207946 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL10843678 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL1934152 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 | |
| SCHEMBL4762341 | 1.00 | KDM4E (0.74) | KDM4ETSHRHSD17B10HTTCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117936807-A | Preparation method and application of alkaline fuel cell catalyst layer containing high water-retaining property and high ion conductivity additive | 中国科学院山西煤炭化学研究所 | 2024-04-26 | — | — | CN | claimed |
| CN-117204433-B | Application and preparation method of compound 1-methyl-1, 2,3, 4-tetrahydro-beta-carboline-3-carboxylic acid | 山东蓬勃生物科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| US-20240082274-A1 | FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION | TURTLE BEAR HOLDINGS, LLC | 2024-03-14 | — | — | US | claimed |
| EP-4333838-A1 | FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION | Turtle Bear Holdings, LLC (US) | 2024-03-13 | — | — | EP | claimed |
| CN-117204433-A | Application and preparation method of compound 1-methyl-1, 2,3, 4-tetrahydro-beta-carboline-3-carboxylic acid | 山东蓬勃生物科技有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-112168846-A | Lactobacillus plantarum TCI378 strain and application of metabolite thereof in fat reduction | 大江生医股份有限公司 | 2021-01-05 | — | — | CN | claimed |
| EP-3188721-B1 | HUMAN THERAPEUTIC AGENTS | ANKH LIFE SCIENCES LTD (IE) | 2019-06-12 | — | — | EP | claimed |
| CN-109134606-A | 1,1- dihydroxymethyl-tetrahydro-beta-carboline -3- formyl-GRGDV, synthesis, activity and application | 首都医科大学 | 2019-01-04 | — | — | CN | claimed |
| CN-109134607-A | 1,1- dihydroxymethyl-tetrahydro-beta-carboline -3- formyl-GRGDS, synthesis, activity and application | 首都医科大学 | 2019-01-04 | — | — | CN | claimed |
| CN-109134603-A | 1,1- dihydroxymethyl-tetrahydro-beta-carboline -3- formyl-GYIGSR, synthesis, activity and application | 首都医科大学 | 2019-01-04 | — | — | CN | claimed |
| CN-109134604-A | 1,1- dihydroxymethyl-tetrahydro-beta-carboline -3- formyl-GRGDF, synthesis, activity and application | 首都医科大学 | 2019-01-04 | — | — | CN | claimed |
| CN-109134605-A | 1,1- dihydroxymethyl-tetrahydro-beta-carboline -3- formyl-GYIGSK, synthesis, activity and application | 首都医科大学 | 2019-01-04 | — | — | CN | claimed |
| CN-109111502-A | 1,1- dihydroxymethyl-tetrahydro-beta-carboline -3- formyl-GGPRP, synthesis, activity and application | 首都医科大学 | 2019-01-01 | — | — | CN | claimed |
| CN-108976283-A | 1,1- dihydroxymethyl-tetrahydro-beta-carboline -3- formyl-GLDV, synthesis, activity and application | 首都医科大学 | 2018-12-11 | — | — | CN | claimed |
| CN-104419326-A | Slurry composition for chemical mechanical polishing | COWON INNOTECH INC | 2015-03-18 | — | — | CN | claimed |
| WO-2008077194-A1 | RECEPTOR AGONISTS | XENOME LTD (AU) | 2008-07-03 | — | — | WO | claimed |
| CN-117936807-A | Preparation method and application of alkaline fuel cell catalyst layer containing high water-retaining property and high ion conductivity additive | 中国科学院山西煤炭化学研究所 | 2024-04-26 | — | — | CN | disclosed |
| CN-117204433-B | Application and preparation method of compound 1-methyl-1, 2,3, 4-tetrahydro-beta-carboline-3-carboxylic acid | 山东蓬勃生物科技有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2004113336-A1 | CARBOLINE AND BETACARBOLINE DERIVATIVES FOR USE AS HDAC ENZYME INHIBITORS | CHROMA THERAPEUTICS LIMITED (GB) | 2004-12-29 | — | — | WO | disclosed |
| EP-0129031-A2 | Antimutagenic agent | SUNTORY LIMITED (JP) | 1984-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240082274-A1 | FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION | MAOB, TPSG1, TPSB2 | KDM4E 1553/4885TSHR 4523/4885HSD17B10 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.